ERIKA LUTKINS: Open Payments
NPI 1437513561 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 34 payments from 11 companies in 2025. Trend: 2023 $540 · 2024 $1,175 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $163 |
| UCB, Inc. | 6 | $132 |
| Organon LLC | 4 | $97 |
| ABBVIE INC. | 4 | $70 |
| Incyte Corporation | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Botanix SB Inc | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
| REVANCE THERAPEUTICS, INC. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: TREMFYA, Bimzelx, BOTOX, OPZELURA, DUPIXENT, SOFDRA, DAXXIFY, Winlevi.
Industry payments across PA — which companies pay providers there.
